Frontiers in Oncology | Hematologic Malignancies

Review

Published on 25 Nov 2022

Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies

in Hematologic Malignancies

Masamitsu Yanada
Kaito Harada
Yoshimitsu Shimomura
Yasuyuki Arai
Takaaki Konuma

Frontiers in Oncology

doi 10.3389/fonc.2022.1050633

7,571 views
9 citations

Case Report

Published on 25 Nov 2022

Multiple myeloma with isolated central nervous system relapse after autologous stem cell transplantation: A case report and review of the literature

in Hematologic Malignancies

Xian Li
Weiqin Wang
Xiaohong Zhang
Yun Liang

Frontiers in Oncology

doi 10.3389/fonc.2022.1027585

2,786 views
2 citations

Review

Published on 24 Nov 2022

Innovation in BCMA CAR-T therapy: Building beyond the Model T

in Hematologic Malignancies

Rahul Banerjee
Sarah S. Lee
Andrew J. Cowan

Frontiers in Oncology

doi 10.3389/fonc.2022.1070353

8,000 views
10 citations

Case Report

Published on 24 Nov 2022

Anti-CD19 chimeric antigen receptor T-cell followed by interferon−α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report

in Hematologic Malignancies

Jing Ni
Junjie Zhou
Zhangbiao Long
Xin Chen
Xiaowen Chen
Jian Hong
Xinglin Liang
Qingsheng Li
Ruixiang Xia
Jian Ge

Frontiers in Oncology

doi 10.3389/fonc.2022.1021786

1,692 views

Original Research

Published on 24 Nov 2022

Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)

in Hematologic Malignancies

Clàudia Pla
Marta Solans
Alberto Ameijide
Arantza Sanvisens
Marià Carulla
María Dolores Rojas
María Araceli Alemán
Isabel Sáez-Lloret
Cristina Díaz-del-Campo
Ana Isabel Marcos-Navarro

Frontiers in Oncology

doi 10.3389/fonc.2022.1046307

5,383 views
5 citations

Mini Review

Published on 24 Nov 2022

Advances in the understanding and treatment of Cutaneous T-cell Lymphoma

in Hematologic Malignancies

Farrah S. Bakr
Sean J. Whittaker

Frontiers in Oncology

doi 10.3389/fonc.2022.1043254

4,131 views
5 citations

Original Research

Published on 24 Nov 2022

In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1

in Hematologic Malignancies

Yixin Luo
Maarten H. Vermeer
Frank R. de Gruijl
Willem H. Zoutman
Marjolein Sluijter
Thorbald van Hall
Cornelis P. Tensen

Frontiers in Oncology

doi 10.3389/fonc.2022.1031052

3,245 views
5 citations

Original Research

Published on 24 Nov 2022

The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

in Hematologic Malignancies

Sara Villar
Beñat Ariceta
Xabier Agirre
Aura Daniela Urribarri
Rosa Ayala
David Martínez-Cuadrón
Juan Miguel Bergua
Susana Vives
Lorenzo Algarra
Mar Tormo

Frontiers in Oncology

doi 10.3389/fonc.2022.1054458

2,902 views
6 citations

Original Research

Published on 23 Nov 2022

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients

in Hematologic Malignancies

Ge Yan
Huangmin Li
Yiding Zhang
Chenyan Xia
Mengxiao Wang
Yu Jia
Jin Shang
Zhanzheng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1012889

2,484 views
8 citations

Original Research

Published on 23 Nov 2022

A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment

in Hematologic Malignancies

Ja Min Byun
Ho Young Kim
Seung-Hyun Nam
Ho-Jin Shin
Seulki Song
Jinny Park
Sang Hoon Han
Yong Park
Young Jin Yuh
Yeung-Chul Mun

Frontiers in Oncology

doi 10.3389/fonc.2022.989984

2,806 views
1 citation

Case Report

Published on 22 Nov 2022

Case report: Double L611S/V617L JAK2 mutation in a patient with polycythemia vera originally diagnosed with essential thrombocythemia

in Hematologic Malignancies

Xiao-qing Li
Jia-jun Liu
Cheng-cheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.937362

1,961 views
1 citation

Original Research

Published on 21 Nov 2022

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study

in Hematologic Malignancies

Xin-Yu Zhuang
Zheng-Tai Sun
Yue Xu
Ya-Ru Ren
Ying-Jie Chen
Feng Chen
Xiao Ma
Xiao-Wen Tang
Xiao-Feng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1040679

1,488 views

Brief Research Report

Published on 21 Nov 2022

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study

in Hematologic Malignancies

Andrea Visentin
Francesca Romana Mauro
Gioachino Catania
Alberto Fresa
Candida Vitale
Alessandro Sanna
Veronica Mattiello
Francesca Cibien
Paolo Sportoletti
Massimo Gentile

Frontiers in Oncology

doi 10.3389/fonc.2022.1033413

3,313 views
11 citations

Review

Published on 18 Nov 2022

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond

in Hematologic Malignancies

Cyrus R. Kumana
Yok-Lam Kwong
Harinder Gill

Frontiers in Oncology

doi 10.3389/fonc.2022.1026478

4,310 views
4 citations

Original Research

Published on 17 Nov 2022

Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma

in Hematologic Malignancies

Tao Guan
Min Zhang
Xiaolan Liu
Jing Li
Beibei Xin
Yanxin Ren
Yuchao Yang
Hui Wang
Mengjing Zhao
Yunpeng Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1003957

3,860 views
5 citations

Original Research

Published on 17 Nov 2022

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis

in Hematologic Malignancies

Hongye Gao
Meng Wu
Shaoxuan Hu
Ning Ding
Xinqiang Ji
Lan Mi
Xiaopei Wang
Yuqin Song
Jun Zhu
Weiping Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1039888

2,180 views
3 citations